Christopher W. Krueger, SVP & CBO at Ardea Biosciences, Inc./DE (RDEA), sold 3,000 shares at $18.67 ($57K) on 2009-09-23, disclosed to the SEC on 2009-09-24.
Scheduled sale ($57k) by SVP & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.67 | 2,200 | $41K | 72.5% |
| 2 | $19.49 | 800 | $16K | 27.5% |
| Total | $18.89 avg | 3,000 | $57K | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |